Could cancer drugs be the future of Alzheimer's treatment?
Alzheimer's cases are rising in the United States and worldwide due to an aging population, but there is no cure for the disease. Attempts to develop new treatments that slow the disease's progress, rather than lessen symptoms, have frequently failed.
Only two drugs — the antibody therapies Leqembi and Kisunla — are currently approved by the Food and Drug Administration to slow the progression of early Alzheimer's, and scientists say their benefits are limited.
Some pharmaceutical companies have halted or abandoned their Alzheimer's drug development programs because of unsuccessful trials. Others are trying to use existing medications, including popular weight loss drugs, to combat Alzheimer's.
With that in mind, researchers at the University of California, San Francisco conducted a broad search for drugs that could be repurposed to treat the condition — in theory, reducing the time in which the drugs could be made available to patients. They scoured a database of more than 1,300 drugs of various classes, including antipsychotics, antibiotics, antifungals and chemotherapy drugs. Then, they looked at how those drugs affected gene expression.
Their new study, published Monday in the journal Cell, identified two cancer drugs as the best candidates to lower Alzheimer's risk in patients. When combined, the drugs seemed to slow or reverse Alzheimer's symptoms in mice. One of the drugs is normally used to treat breast cancer, while the other is effective against colon and lung cancer.
Alzheimer's disease is associated with significant changes in the way genes are expressed in the brain, leading to the increased production of certain proteins and the decreased production of others. These imbalances may disrupt brain function and contribute to symptoms like memory loss.
Fewer than 90 drugs in the researchers' database reversed the expression of signature Alzheimer's-related genes in human brain cells. And five drugs in particular seemed to lower the risk of Alzheimer's in actual patients, based on electronic medical records. The authors ultimately selected two of those drugs, both approved by the FDA to treat cancer, to test in mice.
'We didn't expect cancer drugs to come up' as the most promising, said Marina Sirota, a co-author of the study and interim director of the UCSF Bakar Computational Health Sciences Institute.
The authors said the breast cancer drug letrozole seemed to change gene expression in nerve cells. And the colon and lung cancer drug irinotecan seemed to change gene expression in glial cells, which support the nervous system. Alzheimer's can destroy nerve cells and cause glial cells to proliferate, creating inflammation in the brain.
In a 2020 study, breast cancer patients who received letrozole were less likely to develop Alzheimer's than patients who did not receive the drug. Colorectal cancer survivors treated with irinotecan also had a decreased Alzheimer's risk, according to a 2021 study.
After testing the drugs in mice, the study authors found that the two-drug combo reversed brain degeneration and improved memory in mice that had developed hallmarks of Alzheimer's as they aged.
Because results in mice often don't translate to humans, the researchers hope to test the drugs in a clinical trial with Alzheimer's patients.
'Developing a new drug can take hundreds of millions, or even billions, of dollars, on average take more than 10 years. For this repurposed drug, usually it just takes two or three years, and then you can go to the clinical trial and the cost is much, much lower,' said Dr. Yadong Huang, a co-author of the study and professor of neurology at UCSF.
'We still haven't generated or produced any very effective drugs that can really slow dramatically the cognitive decline,' he added.
Part of the difficulty in developing drugs for Alzheimer's is the complexity of the disease. Its exact cause is largely unknown.
For now, the authors said, it's unclear exactly why the cancer drugs seem to work against Alzheimer's. One theory is that the breast cancer drug blocks the production of estrogen, a hormone that controls the expression of a large number of genes. The colon and lung cancer drug may also block inflammation in the brain by preventing the proliferation of glial cells — though Huang said there are other possibilities.
Dr. Melanie McReynolds, an assistant professor of biochemistry at Pennsylvania State University, who was not involved in the study, offered another theory.
Her research has suggested that a different type of cancer drug could help treat Alzheimer's by regulating glucose metabolism, the process by which cells make energy. McReynolds said the process is necessary for various brain cells to communicate with each other.
'With aging, with stress, with diseases, that line of communication is disrupted,' she said.
McReynolds said the drug combo tested in the new study might reverse metabolic decline — what she called 'the secret for contributing to better outcomes with Alzheimer's.'
But assessing how Alzheimer's patients tolerate the combination of cancer drugs will be important. Letrozole can cause hot flashes and irinotecan can cause severe diarrhea. Both drugs can lead to nausea and vomiting.
'These drugs have huge side effects, so you need to always balance and figure out whether those types of side effects would be amenable to somebody with Alzheimer's,' Sirota said. 'It's not that it's a slam dunk.'
This article was originally published on NBCNews.com
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
an hour ago
- CBS News
Northwestern study finds California life expectancy yet to recover since COVID-19
A new study from Northwestern University found that life expectancy in California has not returned to pre-pandemic levels, data that could indicate similar national trends. The study, published in the Journal of the American Medical Association, found that overdoses and cardiovascular diseases were the leading causes of life expectancy loss in California. COVID-19 also remained a contributing factor. Hannes Schwandt, Northwestern professor and lead researcher of the study, and his team analyzed California data because it is comprehensive and typically published ahead of the Centers for Disease Control and Prevention's national data. The researchers used California's Comprehensive Death Files and obtained population counts for calculating mortality rates from the American Community Survey. "California is the biggest state [by population], so it gives us an idea of trends," he said. Life expectancy is the estimated lifespan of a human based on prevailing age specific mortality rates, according to Northwestern University. "2020 was bad, 2021 was even worse, and then we didn't see a rebound, or even overshooting in life expectancy the next year. We saw continued deficit in life expectancy compared to 2019," Schwandt said. Schwandt compared it to the 1918 influenza pandemic, in which multiple studies show that life expectancy in the United States rebounded after one to two years, unlike COVID-19, which continues to impact life expectancy over five years later. The study found that Californians' life expectancy dropped nearly a year from 81.4 to 80.5 by 2024. While the life expectancy gap between income groups returned to pre-pandemic levels by 2024 after widening during 2020–2023, disparities between racial groups grew even larger. In 2024, Black people lived on average six and a half years less than white people in California. Black Californians experienced a slower but more prolonged decline in life expectancy: losing four years by 2021 due to COVID deaths, but the gap further widened due to fentanyl overdoses. Hispanic Californians had the most severe single-year life expectancy drop of five years in 2021 due to COVID-19. Still, overdoses and cardiovascular disease continue to reduce their life expectancy by more than a year. Overdoses impacted poor communities the hardest, while cardiovascular disease was the primary cause for the drop in life expectancy for wealthier and white people. "The fentanyl crisis particularly took off in 2020 and continues to be a problem," Schwandt said. Other research studies show a strong correlation between the COVID-19 pandemic and the fentanyl epidemic. A study published in the National Library of Medicine calls the pandemic an "important epoch in the opioid epidemic timeline." Societal disruptions, economic stress, and limited access to treatment increased the risk of overdoses, according to the study. Schwandt also said that overprescribing opioids is a part of the larger problem. In 2024, 87% of opioid overdose deaths in Cook County involved fentanyl. African Americans make up 53% of those total overdose deaths. A Penn State study found that by the start of the pandemic, a Black person over the age of 55 in Illinois, Wisconsin, and Minnesota was 5 times more likely to die of a drug overdose than a white person of the same age. "The good news is that in 2024, overdose deaths did decline for the first time," Scwandt said. "But because they increase so dramatically over the years, we are still in a territory that is unacceptable." Provisional data from the CDC found a nearly 24% decline in US drug overdose deaths. Schwandt said that increased deaths from cardiovascular disease could be potentially linked to obesity and Long COVID. "I think that's a really interesting hypothesis that we should explore more," he said. "Maybe in richer areas, people have more access to COVID treatment and survive, have a higher burden of Long COVID, which then could lead to higher cardiovascular mortality," Schwandt said. Long COVID is an all-encompassing name for the long-term symptoms and health effects a person can experience after contracting COVID-19, regardless of the severity of the case. Long COVID is a disorder that can impact almost all parts of the body, including the heart, brain, immune system, and gastrointestinal system. A 2024 study published in the European Journal of Preventive Cardiology found that "undeniably, the Long COVID syndrome has a multifaceted interplay with the cardiovascular system." The researchers looked at 78 different studies to compile different cardiovascular manifestations of Long COVID and found that cardiac symptoms are the third most common clinical manifestation of the disease. Schwandt examines trends in life expectancy and compares the data in the U.S. to that of other developed countries to see how the U.S. can increase its life expectancy. "Countries like Spain, that have lower incomes, and less technology, and they're healthier and live longer [than the US]," he said. He looks at different causes, areas, and incomes throughout the U.S. and other developed countries to determine who is living the longest and why. Schwandt wants to expand the study once the U.S. numbers are available to researchers. "I'd like to analyze the data in rich and poor populations in other developed countries and compare them to the U.S. experience," he said. "How is the world recovering, and is there anything we can learn from that?"
Health Line
2 hours ago
- Health Line
Ozzy Osbourne Dies at 76 After Long Battle with Parkinson's Disease
The effects of Parkinson's disease are back in the spotlight after the death of singer Ozzy Osbourne. Experts say Parkinson's can cause a wide variety of health issues, from falling to tremors to slow movement to cognitive impairment. They say regular exercise, a balanced diet, and memory games can help ease symptoms. The death of heavy metal singer Ozzy Osbourne is shining a spotlight on the difficulties people have while living with Parkinson's disease. Osbourne, the front man for the 1970s group Black Sabbath, died this week at the age of 76. No official cause of death has been announced. Osbourne had numerous health issues, some of which stemmed from his heavy use of alcohol and drugs. In 2020, the musician and reality television star revealed he had been diagnosed with Parkinson's disease. He said he had sustained injuries the previous year after falling, a common occurrence for people with this neurological condition. Osbourne said in a 2023 interview he had been through 'absolute hell' due to his health issues. Earlier this year, Osbourne's wife, Sharon, reported that her husband was unable to walk due to Parkinson's, but the disease had not affected his voice. Osbourne performed on July 5 at a farewell concert with his former bandmates. Due to his inability to stand or walk, he sat on a throne while he sang. Parkinson's disease can produce a wide variety of health issues The Parkinson's Foundation estimates there are slightly more than 1 million people in the United States living with Parkinson's disease. About 90,000 people in the U.S. are diagnosed with the condition every year. About 96% of those diagnosed are over the age of 50. Parkinson's disease is a nervous system disorder that impacts balance and movement. It's caused by the loss of nerve cells in the brain that control the production of the chemical dopamine. Genetic and environmental factors have been targeted as possible risk factors for Parkinson's. Experts note that a wide variety of health issues can be caused by Parkinson's. Among them: Tremors Rigidity in muscles Slowness of movement Higher risk of falls Cognitive impairment Lower blood pressure Constipation Sexual dysfunction Sleep impairment Slurred speech 'Parkinson's disease has been associated with a host of risks including motor symptoms like tremor, stiffness, and slowness but also non-motor symptoms such as depression, constipation, apathy, and cognitive changes,' said Michael Okun, MD, a medical advisor to the Parkinson's Foundation and the co-author of the book 'The Parkinson's Plan.' 'As the disease progresses, risks of falls, infections, and complications from immobility rise, especially if not properly managed,' he added. Experts say these symptoms can seriously impair a person's daily life. 'Parkinson's disrupts everyday routines including getting dressed, walking, writing, and even speaking,' Okun told Healthline. 'These symptoms commonly worsen and become more challenging over time. The disease also affects mood, energy, and sleep, so it's not just the visible tremor.' Daniel Truong, MD, a neurologist and medical director of the Truong Neuroscience Institute at MemorialCare Orange Coast Medical Center in California and editor in chief of the 'Journal of Clinical Parkinsonism and Related Disorders,' agrees that the limitations produced by Parkinson's can be quite serious. 'It affects the movements due to slowness. The stiffness interferes with movements such as using utensils and buttoning shirts. Rigidity reduces range of motion, comfort, [and] pain,' Troung told Healthline. 'Multitasking and decision making may be impaired, affecting work or managing finances. Depression, anxiety, and apathy can reduce motivation and social engagement,' he added. Truong and Okun both say falling is a chief concern for people living with Parkinson's. 'Falls are a major health concern in people with Parkinson's disease and can lead to a cascade of serious complications that significantly worsen overall health and quality of life,' said Truong. 'Falls are a serious concern in Parkinson's,' added Okun. 'A single fall can lead to broken bones, head injuries, or hospital stays, which can cascade into infections, loss of mobility, and even cognitive decline. Preventing falls through balance training, home safety, and medication adjustments is an essential element to a solid Parkinson's treatment plan.' How to improve quality of life while living with Parkinson's Actor Michael J. Fox was diagnosed with Parkinson's disease in 1991 at the age of 29. The star of the 'Back to the Future' films and an Emmy winner for the television shows 'Family Ties' and 'Spin City' made his diagnosis public in 1998. He formed the Michael J. Fox Foundation for Parkinson's Research in 2000. The organization has raised more than $2 billion for Parkinson's research. Fox has spoken publicly about his life with Parkinson's. The tremors from the condition cause him to constantly sway back and forth. He has been injured from falling numerous times. His speech can be mumbled. The 64-year-old father of four says the disease 'sucks' but 'it didn't defeat me.' Troung and Okun say there are a number of lifestyle practices people with Parkinson's can adopt to help improve their quality of life. Exercise is at the top of the list. Diet is also an important factor. 'People with Parkinson's disease can significantly improve their quality of life through a variety of lifestyle activities,' said Truong. 'These activities help manage symptoms, slow progression, and promote emotional and physical well-being. Regular, targeted exercise improves motor function, balance, mood, and even cognition. These are aerobic exercise, balancing exercise.' 'Exercise is medicine for Parkinson's and can include everything from walking, dancing, and boxing to yoga and tai chi,' added Okun. For diet, Truong recommends: High antioxidant foods Fiber-rich food to prevent constipation Spacing out heavy protein meals He also says cognitive engagement exercises such as puzzles, music therapy, and memory games can be beneficial. Okun says an active lifestyle can pay significant dividends. 'Staying socially and mentally engaged, eating well, sleeping better, and working with a multidisciplinary care team can make a big difference in quality of life,' he said. 'Parkinson's is treatable and should not be a death sentence. It should be a life sentence.'
New York Times
2 hours ago
- New York Times
How Many Steps Do You Really Need in a Day?
Walking 10,000 steps a day has long been a fitness cliché. But new research suggests that the health benefits of walking ramp up until about 7,000 steps — before leveling out. And as daily goals go, that's a little more attainable. The analysis, published today in the medical journal The Lancet Public Health, examined data from 57 studies and found that even moderate amounts of walking were associated with a lower risk of dementia and cardiovascular disease, among other conditions, adding to a wide body of research tying walking to longevity. People who walked 7,000 steps a day (roughly three miles) also had a 47 percent lower risk of death compared with those who walked 2,000 steps, the analysis found. 'It is just as important to walk 7,000 steps a day as it is to take your pills,' said Dr. Joshua Knowles, a cardiologist at Stanford Health Care. The Many Benefits of Walking Decades of research shows that walking improves metabolic health, making the heart stronger and more efficient while also reducing weight, cholesterol and blood sugar levels, said Keith Baar, a physiologist at the University of California, Davis. While most scientific reviews have looked at how higher step counts are linked to lower risk of cardiovascular disease and death, the new analysis examined associations across a much broader range of conditions. For example, the study found that walking 7,000 steps a day was associated with a lower risk of Type 2 diabetes, depressive symptoms and cancer death, when compared with 2,000 steps. Experts said the most surprising finding was the nearly 40 percent lower risk of dementia in people who walked 7,000 versus 2,000 steps a day. While the exact mechanism isn't clear, exercise is linked to new neuron growth, greater blood flow to the brain and less neurological inflammation, said Dr. Nikhil Palekar, the director of the Stony Brook Center of Excellence for Alzheimer's Disease. Want all of The Times? Subscribe.
